BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2368755)

  • 1. Waste of i.v. admixtures in the ADD-Vantage system and a traditional minibag system.
    Billeter M; Nowak MM; Rapp RP; Hunt ML
    Am J Hosp Pharm; 1990 Jul; 47(7):1598-600. PubMed ID: 2368755
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inexpensive microcomputer for intravenous admixture service applications.
    Lang JR
    Am J Hosp Pharm; 1983 Mar; 40(3):406-8. PubMed ID: 6846347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of seven methods of preparing and administering small-volume injections.
    Smith CF; Amen RJ
    Am J Hosp Pharm; 1988 Sep; 45(9):1896-901. PubMed ID: 3228122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring waste in an intravenous admixture program.
    Mitchell SR
    Am J Hosp Pharm; 1987 Jan; 44(1):106-11. PubMed ID: 3826083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for reducing i.v. drug waste and coping with increased workload.
    Hoolihan RJ; Erickson BA
    Hosp Pharm; 1987 Sep; 22(9):871-6. PubMed ID: 10312222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringes versus minibags as an intravenous admixture system: a comparison of cost and nursing preference.
    Gin A; Martens D; Dobson K; Hall K
    Can J Hosp Pharm; 1987 Jun; 40(3):81-5. PubMed ID: 10282581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing waste: a significant cost containment measure in an i.v. additive program.
    Coppola PA; Cassidy AP
    Hosp Pharm; 1987 Dec; 22(12):1215-6, 1246. PubMed ID: 10285376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous recording system for I.V. admixtures.
    Finch ME
    Am J Hosp Pharm; 1981 Nov; 38(11):1672, 1674. PubMed ID: 7304617
    [No Abstract]   [Full Text] [Related]  

  • 11. Justification of a pharmacy intravenous admixture service in an Australian hospital.
    Plumridge RJ; Maher M
    Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of product waste in i.v. admixture programs.
    Vogel DP; Eck TA; Witte KW
    Am J Hosp Pharm; 1986 Apr; 43(4):952-3. PubMed ID: 3706344
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing i.v. waste to under 2.25 percent.
    Newhouse JG; Paul VM; Waugh NA; Frye CB
    Hosp Pharm; 1988 Mar; 23(3):241-2, 246-7. PubMed ID: 10312459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcosting method for small-volume injectables.
    Hatoum HT; Witte KW; Biedron GT; Hutchinson RA
    Am J Hosp Pharm; 1986 Feb; 43(2):348-54. PubMed ID: 3953595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considering product features and costs in selecting a system for intermittent i.v. drug delivery.
    Rapp RP
    Am J Hosp Pharm; 1987 Nov; 44(11):2533-8. PubMed ID: 3318417
    [No Abstract]   [Full Text] [Related]  

  • 20. Decision analysis applied to the purchase of frozen premixed intravenous admixtures.
    Witte KW; Eck TA; Vogel DP
    Am J Hosp Pharm; 1985 Apr; 42(4):835-9. PubMed ID: 4014235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.